Zomig is branded Zolmitriptan and comes in the form of tablets, orodispersible and a nasal spray.
Rated 9.8/10 based upon 27 customer reviews.
Based on 27 independent customer reviews taken by Feefo (see all Feefo Reviews ), Google and Trustpilot (see all Trustpilot Reviews).
At Pharmica, we aspire to provide exceptional patient care and take great pride in our customer service. Read 27 of our independent customer feedback for Zomig below or visit Feefo, Trustpilot and Google directly to see all our reviews.
Product Review:
"Excellent"
"Great service, product and price."
Service Review:
"Great service, quality product, good price."
"It works for my menstrual migraines. I find the orodispersible tablets convenient and the citrus flavour is mild & tolerable."
"Life is so busy and this service is extremely convenient. My experience has been faultless so far and I have been impressed with delivery time and communication at every point of the process. Recommend."
"Quality product"
"Fast efficient service and quality product."
"Excellent service with every order"
"Order despatched in plenty of time but not delivered. Presumed lost in transit. Replacement sent via tracked delivery with no questions asked"
"Good product , lifted migraine within the hour"
"Highly recommended, arrived on time would order again"
"Very straightforward purchase process"
"Always on time and what I need."
"Best results are obtained with this brand"
"Excellent service"
"Excellent service. Very prompt and reasonably priced with reminders to ensure I never run out of my prescription. Very happy."
"Excellent service, prompt and reasonably priced. It makes it so easy with reminders to ensure that I have my prescription in time."
"Products arrived safely in great shape"
"Great seamless service. Thank you. I’ll definetely work woth you again."
All reviews externally verified by Feefo and Trustpilot
We use cookies to improve your experience. Continued use indicates your consent.
We use cookies to improve your experience. Continued use indicates consent.
